Strikingly, combined gas plasma–ICB increased remission rates compared to anti‐PD1 and gas plasma monotreatments (Figure 4d) and reduced melanoma growth progression in tumor‐bearing animals (Figure 4e). This evidence concerns the gene PDCD1 and melanoma.